Form 4: Amgen CFO Peter Griffith Reports Stock Disposition
Statement of Changes in Beneficial Ownership
Amgen EVP and CFO Peter H. Griffith reported the disposition of 1,433 shares of common stock to cover tax obligations.
Summary
- Peter H. Griffith, EVP and CFO of Amgen Inc., disposed of a total of 1,433 shares of common stock on May 2, 2026.
- The shares were disposed of in two transactions of 746 shares and 687 shares, both at a price of $329.82 per share.
- The transactions were executed to satisfy tax withholding obligations related to the vesting of equity awards.
- Following these transactions, the reporting person maintains direct beneficial ownership of 47,568 shares of Amgen common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax compliance rather than a change in the executive's outlook on the company.
Positives
- The transaction was a routine administrative action related to tax withholding rather than a discretionary sale of shares.
Negatives
- Reduction in the reporting person's direct equity stake in the company.
Risks
- None identified; this is a standard regulatory disclosure for executive tax obligations.
Future Outlook
No forward-looking guidance or strategic outlook provided in this filing.
Industry Context
StockSavvy.ai notes that routine Form 4 filings regarding tax withholding are standard practice for executives in the biotechnology sector and do not typically signal changes in corporate strategy or management sentiment.
Comparison to Industry Standards
- The transaction aligns with standard executive compensation practices observed at large-cap pharmaceutical companies like Pfizer, Gilead, and AbbVie, where equity vesting often triggers automatic tax withholding sales.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was a non-discretionary tax withholding event.
Next Steps
- No future actions or milestones mentioned.
Key Dates
| Date | Description |
|---|---|
| 05/02/2026 | Date of the reported stock disposition transactions. |
| 05/04/2026 | Date the Form 4 was signed by the reporting person. |
Keywords
Amgen, AMGN, Form 4, Insider Trading, CFO, Equity Compensation, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.